<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">04187</article-id><article-id pub-id-type="doi">10.7554/eLife.04187</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Crystal structure of PfRh5, an essential <italic>P. falciparum</italic> ligand for invasion of human erythrocytes</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-17012"><name><surname>Chen</surname><given-names>Lin</given-names></name><aff><addr-line><named-content content-type="department">Division of Infection and Immunity</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17249"><name><surname>Xu</surname><given-names>Yibin</given-names></name><aff><addr-line><named-content content-type="department">Division of Structural biology</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17250"><name><surname>Healer</surname><given-names>Julie</given-names></name><aff><addr-line><named-content content-type="department">Division of Infection and Immunity</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17251"><name><surname>Thompson</surname><given-names>Jenny K</given-names></name><aff><addr-line><named-content content-type="department">DIvision of Infection and Immunity</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17252"><name><surname>Smith</surname><given-names>Brian J</given-names></name><aff><addr-line><named-content content-type="department">Department of Chemistry, La Trobe Institute for Molecular Science</named-content></addr-line>, <institution>La Trobe University</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17253"><name><surname>Lawrence</surname><given-names>Michael C</given-names></name><aff><addr-line><named-content content-type="department">Division of Structural Biology</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16287"><name><surname>Cowman</surname><given-names>Alan F</given-names></name><aff><addr-line><named-content content-type="department">Division of Infection and Immunity</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country><email>cowman@wehi.edu.au</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1050"><name><surname>Brakhage</surname><given-names>Axel</given-names></name><role>Reviewing editor</role><aff><institution>Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute</institution>, <country>Germany</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>10</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e04187</elocation-id><supplementary-material><ext-link xlink:href="elife-04187-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>29</day><month>07</month><year>2014</year></date><date date-type="accepted"><day>07</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Chen et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Chen et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p><italic>Plasmodium falciparum</italic> causes the most severe form of malaria in humans and is responsible for over 700,000 deaths annually. It is an obligate intracellular parasite and invades erythrocytes where it grows in a relatively protected niche. Invasion of erythrocytes is essential for parasite survival and this involves interplay of multiple protein-protein interactions. One of the most important interactions is binding of parasite invasion ligand families EBLs and PfRhs to host receptors on the surface of erythrocytes. PfRh5 is the only essential invasion ligand within the PfRh family and is an important vaccine candidate. PfRh5 binds the host receptor basigin. Here we have determined the crystal structure of PfRh5 using diffraction data to 2.18 Å resolution. PfRh5 exhibits a novel fold comprising nine mostly-anti-parallel α-helices encasing a N-terminal β-hairpin, with the overall shape being an elliptical disk. This is the first three-dimensional structure determined for the PfRh family of proteins.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>